Peer-reviewedCC BYHemaSphere
Interpreting long‐term response to rituximab in immune thrombocytopenia: Cohort construction, treatment attribution, and dynamic prognostication
- 1Department of Hematology The Second Qilu Hospital of Shandong University Jinan Shandong China
Related
- Rituximab-induced Acute Thrombocytopenia in Systemic Sclerosis: A Case Report of Two Cases
- Genomic foundation models extend clinicopathologic and transcriptomic prognostication in soft tissue sarcoma
- EASIX for Long-Term Prognostication in Hospitalized Heart Failure with Preserved Ejection Fraction: Incremental Value Beyond Clinical Risk Markers
- Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma
- Validation and Performance of Five Upper Gastrointestinal Bleeding Prognostication Scores in a Single-Centre United Kingdom Cohort of over 1000 Patients
BibTeX
@article{zhou2026interpreting,
title = {{Interpreting long‐term response to rituximab in immune thrombocytopenia: Cohort construction, treatment attribution, and dynamic prognostication}},
author = {Xin Zhou and Ningning Shan},
journal = {HemaSphere},
year = {2026},
month = oct,
doi = {10.1002/hem3.70519},
url = {https://doi.org/10.1002/hem3.70519},
note = {CC BY},
}
RIS
TY - JOUR
TI - Interpreting long‐term response to rituximab in immune thrombocytopenia: Cohort construction, treatment attribution, and dynamic prognostication
AU - Xin Zhou
AU - Ningning Shan
PY - 2026
DA - 2026/10/29
JO - HemaSphere
DO - 10.1002/hem3.70519
UR - https://doi.org/10.1002/hem3.70519
SN - 2572-9241
ER -